Showing results (141-150 of 214) with videos related to
Sort By:
Pageof 22
The EMBO Journal|July 2, 2004
VEGF-null cells require PDGFR alpha signaling-mediated stromal fibroblast recruitment for tumorigenesisJianying Dong, Jeremy Grunstein, Max Tejada, et al.Endocrinology|October 31, 2013
Loss of vascular endothelial growth factor A (VEGFA) isoforms in the testes of male mice causes subfertility, reduces sperm numbers, and alters expression of genes that regulate undifferentiated spermatogoniaNingxia Lu, Kevin M Sargent, Debra T Clopton, et al.Nature Medicine|August 6, 2013
An interleukin-17-mediated paracrine network promotes tumor resistance to anti-angiogenic therapyAlicia S Chung, Xiumin Wu, Guanglei Zhuang, et al.Immunity|July 30, 2013
Oncology meets immunology: the cancer-immunity cycleDaniel S Chen, Ira MellmanNature|January 20, 2017
Elements of cancer immunity and the cancer-immune set pointDaniel S Chen, Ira MellmanCancer Journal (Sudbury, Mass.)|August 18, 2018
Combinations of Bevacizumab With Cancer ImmunotherapyDaniel S Chen, Herbert HurwitzDevelopmental Biology|October 11, 2003
Cortical and retinal defects caused by dosage-dependent reductions in VEGF-A paracrine signalingJody J Haigh, Paula I Morelli, Holger Gerhardt, et al.Science Signaling|April 18, 2013
Phosphoproteomic analysis implicates the mTORC2-FoxO1 axis in VEGF signaling and feedback activation of receptor tyrosine kinasesGuanglei Zhuang, Kebing Yu, Zhaoshi Jiang, et al.The New England Journal of Medicine|June 4, 2004
Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancerHerbert Hurwitz, Louis Fehrenbacher, William Novotny, et al.Pageof 22